Huons Global Co., Ltd. Logo

Huons Global Co., Ltd.

A healthcare holding company that develops and sells pharmaceuticals and cosmetics.

084110 | KO

Overview

Corporate Details

ISIN(s):
KR7084110006
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 9층, 성남시

Description

Huons Global Co., Ltd. is a holding company for a total healthcare group that provides medical solutions for human health. Through its various subsidiaries, the company engages in the development, manufacturing, and sale of a diverse portfolio that includes pharmaceutical products, cosmetics, and health-functional food components. The group's pharmaceutical offerings focus on areas such as the nervous and sensory systems. Committed to innovation, the company actively expands its research and development efforts to secure new growth engines and advance its presence in the global healthcare market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-11 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.4 KB
2025-02-11 00:00
매출액또는손익구조30%(대규모법인은15%)미만변동(자율공시)
Korean 11.5 KB
2025-02-11 00:00
현금ㆍ현물배당결정
Korean 9.4 KB
2025-01-31 00:00
주식등의대량보유상황보고서(일반)
Korean 90.4 KB
2025-01-10 00:00
기업설명회(IR)개최
Korean 6.8 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-31 00:00
대표이사변경(자회사의 주요경영사항)
Korean 9.6 KB
2024-12-18 00:00
[기재정정]주요사항보고서(회사분할합병결정)(자회사의 주요경영사항)
Korean 182.6 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-12-16 00:00
주요사항보고서(자기주식취득신탁계약체결결정)(자회사의 주요경영사항)
Korean 24.3 KB
2024-12-16 00:00
주요사항보고서(회사분할합병결정)(자회사의 주요경영사항)
Korean 168.3 KB
2024-11-28 00:00
신탁계약해지결과보고서
Korean 19.9 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.5 MB
2024-10-30 00:00
주식등의대량보유상황보고서(일반)
Korean 90.1 KB
2024-08-30 00:00
신탁계약에의한취득상황보고서
Korean 53.4 KB

Automate Your Workflow. Get a real-time feed of all Huons Global Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Huons Global Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Huons Global Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.